Form SC 13D - General Statement of Acquisition of Beneficial Ownership:
SEC Accession No. 0000947871-24-000770
Filing Date
2024-09-23
Accepted
2024-09-23 18:44:56
Documents
2
Group Members
ORBIMED CAPITAL GP VIII LLC

Document Format Files

Seq Description Document Type Size
1 SCHEDULE 13D ss3902792_sc13d.htm SC 13D 87626
2 JOINT FILING AGREEMENT ss3902792_ex9901.htm EX-99.1 5513
  Complete submission text file 0000947871-24-000770.txt   95002
Mailing Address 601 LEXINGTON AVENUE 54TH FLOOR NEW YORK NY 10022
Business Address 601 LEXINGTON AVENUE 54TH FLOOR NEW YORK NY 10022 (212) 739-6400
ORBIMED ADVISORS LLC (Filed by) CIK: 0001055951 (see all company filings)

EIN.: 133976876 | State of Incorp.: DE
Type: SC 13D

Mailing Address 12 PENNS TRAIL NEWTOWN PA 18940
Business Address 12 PENNS TRAIL NEWTOWN PA 18940 267-759-3680
Traws Pharma, Inc. (Subject) CIK: 0001130598 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D | Act: 34 | File No.: 005-87566 | Film No.: 241317288
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)